Acquisition Growth The HWP Group has a recent acquisition of GMAS (Global Market Access Solutions) in 2026, signaling a strategic expansion into market access and health economics. This provides cross-sell opportunities to existing life sciences clients seeking end-to-end solutions from medical communications to payer strategies and access analytics.

Market Access Focus With a broadened market access capability and a history of supporting life sciences companies across therapeutic areas, there is a clear sales opening to position HWP as a one-stop partner for medical affairs, medical marketing, and payer strategy, appealing to large global brands seeking integrated offerings.

Senior Leadership Leadership momentum includes a president and new chief compliance officer with operational oversight, indicating a stable, growth-oriented organization. This can be leveraged to pursue strategic deals, value-based contracts, and enterprise-level partnerships with compliance and governance assurances.

Revenue Positioning Reported revenue in the broad range of one to several billion dollars suggests HWP operates with high client volumes and large project scopes. This creates sales opportunities for scalable service packages, multi-year engagements, and tiered solutions across medical affairs, marketing, and market access.

Global Delivery Existing capabilities in in-person, digital, and virtual engagements, plus a global footprint via GMAS, indicate readiness to support multinational life sciences clients with distributed teams, enabling cross-border trials, global medical affairs, and region-specific market access strategies.